• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: May 11-15, 2009

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

 

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Joshua Sharfstein, Acting Commissioner Food and Drugs5/14/2009Washington, DCTimothy Cote, Janet  Woodcock, Dan Schultz,  Rachel Behrman, John JenkinsMichael Astrue,  (Social Security  Administration) Mrs. Michael Astrue, Peter Saltonstall,  (NORD) Francis Collins,  (NIH, Human  genomeproject) Pamela Gavin, Karen Ignani, (American Health  Insurance Plans) Frank Sasinowski, (NORD, Human Phelps McNamara) Carolyn Asbury,   (NORD, Dana Foundation)National Organization for Rare Disorders (NORD) Partners in Progress 2009 Gala
Jesse Goodman, Chief Scientist and Acting Deputy Commissioner     
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer5/11/09-5/15/09N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs5/11/09-5/15/09N/AN/AN/ANo significant meetings
Randall Lutter, Deputy Commissioner for Policy     
Janet Woodcock, Director, Center for Drug Evaluation and Research5/13/09Washington, DCN/AAl Benson (Northwestern University) Shawn Bishop (Senate Finance Committee) Carolyn Clancy (AHRQ)A forum with leading scientists and policy-makers to discuss recommendations on the future of comparative effectiveness in conjunction with the release of a report using cancer as a case study
Janet Woodcock, Director, Center for Drug Evaluation and Research5/14/09Washington, DCDaniel Shultz, John Jenkins, Rachel BehrmanTommy Thompson ( Akin Gump) Frank Sasinowski (Hyman, Phelps & McNamara) Stephen Groft (NIH)NORD's Rare Disease Partners in Progress Summit
Janet Woodcock, Director, Center for Drug Evaluation and Research5/15/09Chicago, ILJonathan Helfgott, Jeremy Sugarman (Johns Hopkins University), Matthew Whalen (The Pharmaceutical Saftey Institute), Kit Howard (Kestrel Consultants, Inc.)2009 Clinical Research Educational Conference
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs     
Karen Midthun, Acting Director, Center for Biologics Evaluation and Research5/11/09-5/15/09N/AN/AN/ANo significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health5/14/2009Rockville, MDAnthony Watson, Kate Cook, Betty Collins, Markham Luke, Courtney Harper, Bridget Foltz, Arleen Pinkos, Patricia Beaston, Charles Zimliki, Donna-Bea Tillman, Sheila Brown, Joseph Jorgens, Jonathan Sackner-BernsteinLarry Soler, Cynthia Rice, Aaron Kowalski (Juvenile Diabetes Research Foundation), Roy Beck, John Lum (Jaeb Center for Health Research), Phil Phillips (Becker & Associates)Medical device issues
Daniel Schultz, Director, Center for Devices and Radiological Health5/14/2009Rockville, MDRobert Becker, Alberto Gutierrez, Les WeinsteinJonathan Kahan, Randy Prebula (Hogan & Hartson, LLP), Peter levine, Reid Adler, Brian Mansfield (Correlogic Systems, Inc.) P. DishaiaMedical device issues
Stephen Sundlof, Center for Food Safety and Applied Nutrition5/13/2009College Park, MDBarbara Schneeman, Felicia BillingsleaGene Lambert (General Mills)New Clinical Study and Packaging
Bernadette Dunham, Director, Center for Veterinary Medicine05/11-15/09Natal, BrazilSteve Vaughn, Brandi Robinson, Merton Smith, Kevin Greenlees, Dong Yan, Valerie Reeves, Lynn FriedlanderCodex membersCodex Committee on Residues of Veterinary Drugs in Foods
William Slikker, Director, National Center for Toxicological Research5/11/09-5/15/09N/AN/AN/ANo significant meetings
Michael M. Landa, Acting Chief Counsel5/11/09-5/15/09N/AN/AN/ANo significant meetings